Related Experiment Video

Updated: Nov 4, 2025

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
05:21

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay

Published on: September 13, 2024

576

Jab1/Cops5: a promising target for cancer diagnosis and therapy

Chunjue Yuan1,2, Dong Wang1, Guohong Liu3

  • 1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, No.169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei, China.

International Journal of Clinical Oncology
|May 21, 2021
PubMed

Insights

C-Jun activation domain-binding protein 1 (Jab1), also known as COPS5/Csn5, is implicated in cancer development. This study confirms Jab1/Csn5

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • C-Jun activation domain-binding protein 1 (Jab1), also known as COPS5/Csn5, is a key component of the COP9 signalosome complex.
  • Jab1/Csn5 plays critical roles in various cellular processes, including cell cycle regulation and signal transduction.
  • Its dysregulation is linked to oncogenesis by affecting tumor suppressors and oncogenes.

Purpose of the Study:

  • To summarize the multifaceted roles and signaling pathways of Jab1/Csn5 in tumorigenesis.
  • To investigate the differential expression of Jab1/Csn5 across various cancer types and clinical outcomes.
  • To evaluate Jab1/Csn5 as a potential biomarker and therapeutic target in cancer.

Main Methods:

  • Literature review on Jab1/Csn5 functions in cancer.
  • Utilized the Oncomine database for cancer microarray data analysis.
  • Performed statistical analysis to compare Jab1/Csn5 expression in tumor vs. normal tissues, different cancer types, and clinical outcomes.

Main Results:

  • Jab1/Csn5 is overexpressed in a wide range of human tumors.
  • Statistical analysis confirmed significant differential expression of Jab1/Csn5 in various cancers.
  • Expression levels of Jab1/Csn5 correlate with different histological types, cancer types, and clinical prognosis.

Conclusions:

  • Jab1/Csn5 plays a significant role in carcinogenesis.
  • The study validates Jab1/Csn5 as a potential biomarker for cancer diagnosis and prognosis.
  • Jab1/Csn5 represents a promising therapeutic target for developing novel anti-cancer drugs.
Keywords:
CancerJab1/COPS5Oncomine databasePrognostic markerTherapeutic target

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
597